Higher in-home demand to drive growth; PAT CAGR of 53.9% estimated over CY20-22; ‘Add’ retained with TP of Rs 1,015
Cigarette volumes fell by 7% y-o-y; FMCG margins may drive consensus upgrades; TP revised to Rs 250; ‘Add’ maintained
Order wins, monetisation of assets to be key triggers; TP up to Rs 182; ‘Buy’ retained
Ashok Leyland’s (AL) operating performance in Q3FY21 was below consensus estimates as EBITDA margin came in at 5.3%.
Momentum is expected to persist; FY21-23e EPS up 2-3% to factor in better gross margin; TP raised to `4,236; ‘Add’…
FY21/22 PAT up 25/14.5%; RoCEs to rise to 17.8% by FY22e; TP revised to Rs 705
Firm likely to be debt free by FY23e; FY22-23e Ebitda up 6-8%; TP raised to Rs 6,700; re-rating is in…
Jyothy Labs’ (JLL) revenue grew 15% in Q3FY21, higher than the consensus expectations, driven by strong execution – penetrating rural…
Quarterly sales surge to five-year high. OBER recorded its highest ever quarterly sales bookings in five years at Rs9.7billion vs.…
We revise estimate of cumulative slippage run-rate to >13% (earlier 10%) and cumulative credit cost to 6% (5%) over FY21E/FY22E.
Operations in Assam – what will be the game plan: Bandhan has been treading cautiously in Assam – share is…
While it restructured Rs 10.6 bn (0.54% of loans) worth of accounts in Q3FY21, it reduces potential restructuring to ~1.3%…
Key risks, litigation by other contenders on bidding outcome can defer the process; and higher mark-down on acquired portfolio.
Estimated FY21 rental income loss down to 45%; TP raised to Rs 925; ‘Buy’ retained
Promoter pledge an overhang; reinitiated coverage with ‘Buy’ rating and TP of Rs 526
NHPC received Rs 7.34 billion from PFC on account of dues pending from J&K UT through the PFC/REC scheme, under…
Sobha’s Q3FY21 gross sales volumes of 1.13msf worth Rs 8.9bn wereup 6% y-o-y in volume terms and 22% y-o-y in…
With several states facing concerns of bird flu, we believe animal feed and poultry segments of Godrej Agrovet are likely…
